These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 9016768

  • 1. Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.
    Du K, Nicole P, Couvineau A, Laburthe M.
    Biochem Biophys Res Commun; 1997 Jan 13; 230(2):289-92. PubMed ID: 9016768
    [Abstract] [Full Text] [Related]

  • 2. Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship.
    Nicole P, Du K, Couvineau A, Laburthe M.
    J Pharmacol Exp Ther; 1998 Feb 13; 284(2):744-50. PubMed ID: 9454823
    [Abstract] [Full Text] [Related]

  • 3. [Directed mutagenesis of human recombinant receptors of vasoactive intestinal peptide of VIP1 and VIP2 type. Difference in structure-activity relationship].
    Nicole P, Du K, Couvineau A, Laburthe M.
    Gastroenterol Clin Biol; 1997 Feb 13; 21(5):365-9. PubMed ID: 9208011
    [Abstract] [Full Text] [Related]

  • 4. Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP.
    Couvineau A, Gaudin P, Maoret JJ, Rouyer-Fessard C, Nicole P, Laburthe M.
    Biochem Biophys Res Commun; 1995 Jan 05; 206(1):246-52. PubMed ID: 7818527
    [Abstract] [Full Text] [Related]

  • 5. Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane.
    Couvineau A, Fabre C, Gaudin P, Maoret JJ, Laburthe M.
    Biochemistry; 1996 Feb 13; 35(6):1745-52. PubMed ID: 8639654
    [Abstract] [Full Text] [Related]

  • 6. Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC1R).
    Knudsen SM, Tams JW, Fahrenkrug J.
    J Mol Neurosci; 2000 Jun 13; 14(3):137-46. PubMed ID: 10984189
    [Abstract] [Full Text] [Related]

  • 7. Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding.
    Nicole P, Maoret JJ, Couvineau A, Momany FA, Laburthe M.
    Biochem Biophys Res Commun; 2000 Sep 24; 276(2):654-9. PubMed ID: 11027527
    [Abstract] [Full Text] [Related]

  • 8. The human vasoactive intestinal Peptide/Pituitary adenylate cyclase activating peptide receptor 1 (VPAC1): constitutive activation by mutations at threonine 343.
    Gaudin P, Couvineau A, Rouyer-Fessard C, Maoret JJ, Laburthe M.
    Biochem Biophys Res Commun; 1999 Jan 08; 254(1):15-20. PubMed ID: 9920725
    [Abstract] [Full Text] [Related]

  • 9. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
    Nachtergael I, Gaspard N, Langlet C, Robberecht P, Langer I.
    Cell Signal; 2006 Dec 08; 18(12):2121-30. PubMed ID: 16650965
    [Abstract] [Full Text] [Related]

  • 10. Role of cysteine residues in the N-terminal extracellular domain of the human VIP 1 receptor for ligand binding. A site-directed mutagenesis study.
    Gaudin P, Couvineau A, Maoret JJ, Rouyer-Fessard C, Laburthe M.
    Ann N Y Acad Sci; 1996 Dec 26; 805():585-9. PubMed ID: 8993444
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R.
    Mol Cell Neurosci; 2006 Feb 26; 31(2):193-209. PubMed ID: 16226889
    [Abstract] [Full Text] [Related]

  • 12. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor.
    Sreedharan SP, Patel DR, Huang JX, Goetzl EJ.
    Biochem Biophys Res Commun; 1993 Jun 15; 193(2):546-53. PubMed ID: 8390245
    [Abstract] [Full Text] [Related]

  • 13. Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation.
    Langer I, Robberecht P.
    Cell Signal; 2005 Jan 15; 17(1):17-24. PubMed ID: 15451021
    [Abstract] [Full Text] [Related]

  • 14. Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors.
    Gaudin P, Maoret JJ, Couvineau A, Rouyer-Fessard C, Laburthe M.
    J Biol Chem; 1998 Feb 27; 273(9):4990-6. PubMed ID: 9478946
    [Abstract] [Full Text] [Related]

  • 15. Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.
    Marie JC, Rouyer-Fessard C, Couvineau A, Nicole P, Devaud H, El Benna J, Laburthe M.
    Mol Pharmacol; 2003 Dec 27; 64(6):1565-74. PubMed ID: 14645688
    [Abstract] [Full Text] [Related]

  • 16. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun 27; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 17. Molecular evolution of vertebrate VIP receptors and functional characterization of a VIP receptor from goldfish Carassius auratus.
    Chow BK, Yuen TT, Chan KW.
    Gen Comp Endocrinol; 1997 Feb 27; 105(2):176-85. PubMed ID: 9038250
    [Abstract] [Full Text] [Related]

  • 18. Importance of conserved cysteines in the extracellular loops of human PACAP/VIP1 receptor for ligand binding and stimulation of cAMP production.
    Knudsen SM, Tams JW, Wulff BS, Fahrenkrug J.
    Ann N Y Acad Sci; 1998 Dec 11; 865():259-65. PubMed ID: 9928020
    [Abstract] [Full Text] [Related]

  • 19. Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor.
    Langer I, Langlet C, Robberecht P.
    J Mol Endocrinol; 2005 Apr 11; 34(2):405-14. PubMed ID: 15821106
    [Abstract] [Full Text] [Related]

  • 20. Altered ligand dissociation rates in thyrotropin-releasing hormone receptors mutated in glutamine 105 of transmembrane helix III.
    del Camino D, Barros F, Pardo LA, de la Peña P.
    Biochemistry; 1997 Mar 18; 36(11):3308-18. PubMed ID: 9116009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.